Arkolith/Insider Trading/AQST/Form 4

Jung Cassie

Chief Operating OfficerAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Sep 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$311K
Net Open-Market Flow
-$311K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 4, 2025Option exercise(M)25K$3.15$79K321K
Sep 4, 2025Sell(S)62K$5.00$311K283K
Sep 4, 2025Option exercise(M)25K$0.71$18K346K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 4, 2025Option exercise(M)25K—$00
Sep 4, 2025Option exercise(M)25K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-013493) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML